Lassa Virus News and Research

RSS
Lassa virus or Lassa viral haemorrhagic fever is an acute illness of 1-4 weeks duration that occurs in West Africa. Though first described in the 1950s, the virus causing the disease was not identified until 1969. The virus is a single-stranded RNA virus belonging to the virus family Arenaviridae. Lassa fever is known to be endemic in Guinea (Conakry), Liberia, Sierra Leone and parts of Nigeria, but probably exists in other West African countries as well.

Further Reading

Scientists solve structure of key protein from Lassa virus

Scientists solve structure of key protein from Lassa virus

NIH awards Corgenix Medical $600,000 grant to develop diagnostic tests for Ebola and Marburg virus

NIH awards Corgenix Medical $600,000 grant to develop diagnostic tests for Ebola and Marburg virus

NIAID awards Tulane University over $15M to develop Lassa fever vaccine and treatment

NIAID awards Tulane University over $15M to develop Lassa fever vaccine and treatment

NIH awards over $15M for Tulane University's collaborative effort to combat VHF

NIH awards over $15M for Tulane University's collaborative effort to combat VHF

Discovery of new arenavirus associated with hemorrhagic fever – first identified in nearly four decades

Discovery of new arenavirus associated with hemorrhagic fever – first identified in nearly four decades

Researchers develop new strategy for broad spectrum anti-viral drugs

Researchers develop new strategy for broad spectrum anti-viral drugs

Lassa fever reported in Germany

Lassa fever reported in Germany

Vaccine against Lassa fever works in monkeys

Vaccine against Lassa fever works in monkeys

New candidate for a vaccine against Lassa fever

New candidate for a vaccine against Lassa fever